ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,693Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 31

$1.28M Total Retail Price of All Prescriptions

Rank: 1 out of 31

640 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

23% of this provider’s 640 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

15% of this provider’s 640 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 15,875 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
HYDROCHLOROTHIAZIDE 1,055 745 1 11
AMLODIPINE BESYLATE 781 630 2 3
SIMVASTATIN 753 518 3 2
LEVOTHYROXINE SODIUM 706 529 4 7
OMEPRAZOLE 604 339 5 1
FUROSEMIDE 581 368 6 6
POTASSIUM CHLORIDE 562 393 7 10
LISINOPRIL 543 353 8 5
OXYCODONE-ACETAMINOPHEN 448 220 S2 9 37
METOPROLOL TARTRATE 442 257 10 13
NEXIUM 380 249 11 19
METFORMIN HCL 377 191 12 8
HYDROCODONE-ACETAMINOPHEN 372 253 S3 13 4
WARFARIN SODIUM 370 249 14 17
GLIPIZIDE 342 280 15 63
CLONIDINE HCL 326 207 16 36
TRAMADOL HCL 315 229 17 16
DOXYCYCLINE HYCLATE 314 203 18 58
METOPROLOL SUCCINATE 286 208 19 12
GABAPENTIN 285 109 20 14
DILTIAZEM 24HR CD 283 213 21 48
ATENOLOL 269 199 22 22
GLIPIZIDE XL 265 211 23 51
TRAZODONE HCL 256 135 24 25
NIASPAN 248 185 25 60
ZOLPIDEM TARTRATE 232 142 26 21
TAMSULOSIN HCL 230 171 27 28
PROMETHAZINE HCL 228 41 R 28 74
CARVEDILOL 215 167 29 30
CLOPIDOGREL 201 154 30 24
AGGRENOX 190 155 31 119
SYMBICORT 184 108 32 104
ENDOCET 184 56 S2 32 83
FLUOXETINE HCL 184 116 32 77
NAPROXEN 174 120 35 69
IBUPROFEN 172 60 36 67
MICARDIS 164 146 37 134
BUMETANIDE 161 99 38 108
PREDNISONE 161 99 38 46
LOSARTAN POTASSIUM 161 115 38 27
PLAVIX 161 132 38 35
CYCLOBENZAPRINE HCL 156 49 R 42 47
SYNTHROID 147 77 43 32
PROAIR HFA 147 79 43 55
LEVOFLOXACIN 145 103 45 106
CYMBALTA 136 67 46 78
ENALAPRIL MALEATE 133 41 47 70
NOVOLOG 128 101 48 150
ESCITALOPRAM OXALATE 128 76 48 65
AMLODIPINE BESYLATE-BENAZEPRIL 127 97 50 42
METOCLOPRAMIDE HCL 125 62 51 102
AMOX TR-POTASSIUM CLAVULANATE 120 73 52 85
PHENYTOIN SODIUM EXTENDED 119 64 53 105
LEVETIRACETAM 116 41 54 124
VENTOLIN HFA 114 70 55 110
FLUCONAZOLE 114 56 55 112
CRESTOR 113 48 57 20
ATORVASTATIN CALCIUM 110 97 58 15
BENICAR 110 83 58 157
JANUVIA 110 77 58 71
LANOXIN 107 64 61 126
OXYCODONE HCL-ACETAMINOPHEN 107 16 S2 61 86
TRIAMCINOLONE ACETONIDE 106 83 63 159
METHADONE HCL 106 32 S2 63 127
OXYBUTYNIN CHLORIDE 102 65 65 124
LYRICA 102 49 65 138
DIOVAN 99 99 67 45
DONEPEZIL HCL 97 84 68 38
NAMENDA 97 83 68 76
CITALOPRAM HBR 93 70 70 23
METFORMIN HCL ER 92 92 71 54
FENTANYL 90 19 S2 72 131
CIPROFLOXACIN HCL 88 58 73 61
FENOFIBRATE 88 64 73 62
LEVEMIR 85 49 75 117
SPIRIVA 85 41 75 91
ACTOS 82 52 77 95
DIGOXIN 82 54 77 66
ISOSORBIDE MONONITRATE ER 81 50 79 79
CEFUROXIME 80 42 80 171
POLYETHYLENE GLYCOL 3350 80 53 80 44
PANTOPRAZOLE SODIUM 79 56 82 57
CELEBREX 77 54 83 88
CEPHALEXIN 77 52 83 145
HYDRALAZINE HCL 75 67 85 99
RANITIDINE HCL 74 58 86 34
OLANZAPINE 69 35 87 152
HYDROXYZINE HCL 69 56 R 87 179
SPIRONOLACTONE 69 45 87 40
AMIODARONE HCL 67 63 90 145
HUMALOG 65 55 91 182
ALENDRONATE SODIUM 64 41 92 52
MECLIZINE HCL 62 43 93 150
KLOR-CON M20 62 0 93 64
QUINAPRIL HCL 62 50 93 108
BACLOFEN 61 24 96 188
CARBAMAZEPINE 60 25 97 155
SUCRALFATE 60 31 97 190
COMBIVENT 60 30 97 190
GLIMEPIRIDE 59 59 100 26
ALLOPURINOL 59 47 100 29
GLYBURIDE 59 36 R 100 84
NYSTATIN 59 43 100 192
ADVAIR DISKUS 58 47 104 49
COLCRYS 58 39 104 195
BYSTOLIC 57 51 106 90
JANTOVEN 57 57 106 199
BENZTROPINE MESYLATE 55 12 R 108 203
SINGULAIR 55 29 108 101
ROPINIROLE HCL 55 42 108 103
VERAPAMIL ER 54 37 111 116
PAROXETINE HCL 54 29 111 72
PREMARIN 52 31 R 113 122
AZITHROMYCIN 52 26 113 33
CARISOPRODOL 51 21 R 115 113
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 20, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.